Skip to main content

Table 3 Laboratory data

From: Multidisciplinary intervention for adverse events associated with ATZ + BEV therapy: a case report

 

Day14

Day21

Day28

 

sIL-2R

4607

2967

1841

U/mL

  1. sIL-2R Soluble interleukin-2 receptor
Back to article page

Journal of Pharmaceutical Health Care and Sciences

ISSN: 2055-0294

Contact us